Intraoperative Radiation Therapy Market, By Technique (Intraoperative Brachytherapy, Electron Intraoperative Radiation Therapy), By Product (Applicators and Afterloaders Treatment, Planning Systems System/ Accelerators, Other Accessories), By Applications (Brain Tumor, Breast Cancer, Lung Cancer), By End User (Hospitals, Ambulatory Surgical Centers), By Region Analysis - Global Analysis and Industry Forecast Report Till 2030.

The Intraoperative Radiation Therapy Market is projected to grow from $51.3 million to $76.8 million, at a CAGR of 4.58% during the forecast period.

Intraoperative radiation therapy is the use of radiation to treat diseased cells in areas exposed during surgery. It is mainly used in radiation therapy or chemotherapy to treat cancer cells. Due to rapid technological advances globally and innovations in new technologies to treat diseases more discreetly and in a shorter period of time, intraoperative radiation therapy is becoming increasingly popular as an alternative to traditional radiation therapy and has been used in several lucrative ways to treat cancer being used in a way increase in market demand. Improvement in reimbursement scenarios across developed countries coupled with increasing application of intraoperative radiation therapy in medical treatment is driving the market growth.

Market Dynamics:

Drivers:

The intraoperative radiation therapy procedure is associated with a number of advantages, such as targeted radiation, limited treatment time, high precision and radiation control, and minimal radiation exposure to normal tissue. This is especially true for breast cancer, as this mode gives women the option of breast-conserving treatment (tumorectomy). Increasing prevalence of breast cancer is a key factor driving the market growth.

Restraints:

A high level of accuracy is required at every step of the process to achieve maximum tumor control and minimize risk to normal tissue. Problems with interconnectivity between different treatment plans and delivery and monitoring systems can lead to procedural errors, increasing patient risk. These complexities associated with intraoperative radiation therapy hamper the widespread adoption of intraoperative radiation therapy in cancer treatment. These factors are expected to negatively influence the intraoperative radiation therapy market growth during the forecast period.

Opportunities:

Over the years, intraoperative radiation therapy has found important applications as breast-conserving treatment. Along with the increasing applications of intraoperative radiation therapy, technological advances in this field have led to increased cooperation between many manufacturers and research institutions. This is to conduct clinical trials to study the application and efficacy of intraoperative radiation therapy on different cancer types. The main goal of these clinical trials is to analyze and evaluate the feasibility of intraoperative radiation therapy in various cancer applications.

Key Players:

• Ariane Medical Systems, Ltd.

• Eckert & Ziegler Group

• Elekta AB

• GMV Innovating Solutions

• ICAD, Inc.

• IntraOp Medical Corporation

• Sensus Healthcare, Inc.

• Sordina IORT Technologies S.p.A.

• Varian Medical Systems, Inc.

• ZEISS Group

• Becton, Dickinson and Company

Market Segmentation:

Intraoperative Radiation Therapy Market, By Technique

• Intraoperative Brachytherapy

• Electron Intraoperative Radiation Therapy

Intraoperative Radiation Therapy Market, By Product

• Applicators and Afterloaders Treatment

• Planning Systems System/ Accelerators

• Other Accessories

Intraoperative Radiation Therapy Market, By Applications

• Brain Tumor

• Breast Cancer

• Lung Cancer

Intraoperative Radiation Therapy Market, By End User

• Hospitals

• Ambulatory Surgical Centers

Intraoperative Radiation Therapy Market, By Region

• North America

• Europe

• Asia-Pacific

• Latin America

• Middle East & Africa (MEA)

Regional Analysis:

North America is likely to dominate the global radiotherapy treatment market over the projected period, owing to the increasing prevalence of cancer and increasing adoption of radiotherapy as a treatment procedure.

In Europe, increasing investments by government agencies in research and development activities and increasing collaboration among many key players to develop cost-effective radiation therapies for cancer treatment are likely to boost the radiation therapy market share over the forecast period.

Asia Pacific is expected to register significant CAGR in the market owing to growing patient population and regional economic development. In the Middle East and Africa, growing demand for cost-effective options for the treatment of various cancers is likely to propel the intraoperative radiation therapy market growth during the forecast period.

Scope of the report:

User

Tab Content